ZOOLOBELIN 1.8 MG / ML INJECTABLE SOLUTION 2 BOTTLES OF 5 ML ZOOLOBELIN

Indicative

ZOOLOBELIN Adopt normal aseptic procedures for parenteral injections. Special precautions for those administering the product to animals:ZOOLOBELIN, people with known hypersensitivity to the active ingredient should avoid contact with the veterinary medicinal product. Be careful when administering the product. In case of accidental self-injection or with symptoms such as skin rash, swelling of the face, lips or eyes or breathing difficulties, seek medical advice immediately and show the package leaflet or the label to the physician. Overdose: symptoms such as profuse sweating, heart rate changes, paresis, hypothermia, hypotension are reported following overdose. Incompatibility: in the absence of compatibility studies, do not mix with other veterinary medicinal products.

Ingredient matches for Zoolobelin

Lobeline

Lobeline hydrochloride (a derivative of Lobeline) is reported as an ingredient of Zoolobelin in the following countries:

• Italy

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

ZOOLOBELIN 1.8 MG / ML INJECTABLE SOLUTION 2 BOTTLES OF 5 ML

Indicative

Adopt normal aseptic procedures for parenteral injections. Special precautions for those administering the product to animals: people with known hypersensitivity to the active ingredient should avoid contact with the veterinary medicinal product. Be careful when administering the product. In case of accidental self-injection or with symptoms such as skin rash, swelling of the face, lips or eyes or breathing difficulties, seek medical advice immediately and show the package leaflet or the label to the physician. Overdose: symptoms such as profuse sweating, heart rate changes, paresis, hypothermia, hypotension are reported following overdose. Incompatibility: in the absence of compatibility studies, do not mix with other veterinary medicinal products.

Ingredient matches for Zoolobelin

Lobeline

Lobeline hydrochloride (a derivative of Lobeline) is reported as an ingredient of Zoolobelin in the following countries:

• Italy

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.